FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292294906> ?p ?o ?g. }

• W4292294906 abstract "Background Maternal opioid exposure during pregnancy has various effects on neonatal health. Buprenorphine/naloxone and methadone are examples of medications for opioid use disorder (MOUD) used for the treatment of opioid use disorder (OUD). Research comparing the impacts of these MOUD modalities on neonatal outcomes when used to treat pregnant people with OUD remains limited. We evaluated the differences in outcomes between neonates with in-utero exposure to buprenorphine/naloxone versus methadone. Methodology We performed a retrospective cohort chart review between October 15, 2008, and October 15, 2019, evaluating mother/neonate dyads at two medical centers in Michigan. The charts of female patients, aged 18+, with OUD and buprenorphine/naloxone or methadone treatment, were examined. The charts of the corresponding neonates were also examined. Multiple regression analysis was performed. Results In total, 343 mother/infant dyads were included: 99 patients were treated with buprenorphine/naloxone and 232 patients were treated with methadone. The buprenorphine/naloxone group had significant differences in maternal age, hepatitis status, asthma, gestational age in weeks, neonatal intensive care unit (NICU) length of stay (LOS), neonatal opioid withdrawal syndrome (NOWS) peak score, birth head circumference, and birth weight compared to the methadone group at baseline. Adjusted multivariable regression analysis demonstrated neonates with exposure to buprenorphine/naloxone had a NOWS peak score 3.079 points less (95% confidence interval (CI): -4.525, 1.633; p = 0.001) and NICU LOS 8.955 days less (95% CI: -14.399, -3.511; p = 0.001) than neonates exposed to methadone. Conclusions Neonates with in-utero exposure to buprenorphine/naloxone had significantly lower NOWS scores and shorter NICU LOS compared to neonates with in-utero exposure to methadone. These findings demonstrate that buprenorphine/naloxone is potentially a more favorable treatment for the reduction in metrics representing adverse neonatal outcomes in pregnant people with OUD than methadone." @default.
• W4292294906 created "2022-08-19" @default.
• W4292294906 creator A5014638926 @default.
• W4292294906 creator A5022188861 @default.
• W4292294906 creator A5030534346 @default.
• W4292294906 creator A5039357906 @default.
• W4292294906 creator A5050185601 @default.
• W4292294906 creator A5055869517 @default.
• W4292294906 creator A5058511612 @default.
• W4292294906 creator A5073240436 @default.
• W4292294906 creator A5081091640 @default.
• W4292294906 creator A5089445658 @default.
• W4292294906 date "2022-08-08" @default.
• W4292294906 modified "2023-09-26" @default.
• W4292294906 title "Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan" @default.
• W4292294906 cites W1547354143 @default.
• W4292294906 cites W2001965119 @default.
• W4292294906 cites W2009000630 @default.
• W4292294906 cites W2025988777 @default.
• W4292294906 cites W2047822006 @default.
• W4292294906 cites W2100607375 @default.
• W4292294906 cites W2143144451 @default.
• W4292294906 cites W2144733316 @default.
• W4292294906 cites W2167662387 @default.
• W4292294906 cites W2394582682 @default.
• W4292294906 cites W2419293593 @default.
• W4292294906 cites W2436883172 @default.
• W4292294906 cites W2520214195 @default.
• W4292294906 cites W2616462192 @default.
• W4292294906 cites W2765476035 @default.
• W4292294906 cites W2767250259 @default.
• W4292294906 cites W2789656422 @default.
• W4292294906 cites W2789844120 @default.
• W4292294906 cites W2791607419 @default.
• W4292294906 cites W2884371160 @default.
• W4292294906 cites W2909584163 @default.
• W4292294906 cites W2909656440 @default.
• W4292294906 cites W2968556761 @default.
• W4292294906 cites W2978054008 @default.
• W4292294906 cites W2996619358 @default.
• W4292294906 cites W3039861444 @default.
• W4292294906 cites W3093906108 @default.
• W4292294906 cites W3120157478 @default.
• W4292294906 cites W3198085477 @default.
• W4292294906 cites W4231119077 @default.
• W4292294906 doi "https://doi.org/10.7759/cureus.27790" @default.
• W4292294906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36106254" @default.
• W4292294906 hasPublicationYear "2022" @default.
• W4292294906 type Work @default.
• W4292294906 citedByCount "0" @default.
• W4292294906 crossrefType "journal-article" @default.
• W4292294906 hasAuthorship W4292294906A5014638926 @default.
• W4292294906 hasAuthorship W4292294906A5022188861 @default.
• W4292294906 hasAuthorship W4292294906A5030534346 @default.
• W4292294906 hasAuthorship W4292294906A5039357906 @default.
• W4292294906 hasAuthorship W4292294906A5050185601 @default.
• W4292294906 hasAuthorship W4292294906A5055869517 @default.
• W4292294906 hasAuthorship W4292294906A5058511612 @default.
• W4292294906 hasAuthorship W4292294906A5073240436 @default.
• W4292294906 hasAuthorship W4292294906A5081091640 @default.
• W4292294906 hasAuthorship W4292294906A5089445658 @default.
• W4292294906 hasBestOaLocation W42922949061 @default.
• W4292294906 hasConcept C126322002 @default.
• W4292294906 hasConcept C131872663 @default.
• W4292294906 hasConcept C170493617 @default.
• W4292294906 hasConcept C187212893 @default.
• W4292294906 hasConcept C2777091541 @default.
• W4292294906 hasConcept C2778376644 @default.
• W4292294906 hasConcept C2778750930 @default.
• W4292294906 hasConcept C2778767360 @default.
• W4292294906 hasConcept C2778949969 @default.
• W4292294906 hasConcept C2779234561 @default.
• W4292294906 hasConcept C2779418921 @default.
• W4292294906 hasConcept C2781063702 @default.
• W4292294906 hasConcept C42219234 @default.
• W4292294906 hasConcept C54355233 @default.
• W4292294906 hasConcept C71924100 @default.
• W4292294906 hasConcept C86803240 @default.
• W4292294906 hasConceptScore W4292294906C126322002 @default.
• W4292294906 hasConceptScore W4292294906C131872663 @default.
• W4292294906 hasConceptScore W4292294906C170493617 @default.
• W4292294906 hasConceptScore W4292294906C187212893 @default.
• W4292294906 hasConceptScore W4292294906C2777091541 @default.
• W4292294906 hasConceptScore W4292294906C2778376644 @default.
• W4292294906 hasConceptScore W4292294906C2778750930 @default.
• W4292294906 hasConceptScore W4292294906C2778767360 @default.
• W4292294906 hasConceptScore W4292294906C2778949969 @default.
• W4292294906 hasConceptScore W4292294906C2779234561 @default.
• W4292294906 hasConceptScore W4292294906C2779418921 @default.
• W4292294906 hasConceptScore W4292294906C2781063702 @default.
• W4292294906 hasConceptScore W4292294906C42219234 @default.
• W4292294906 hasConceptScore W4292294906C54355233 @default.
• W4292294906 hasConceptScore W4292294906C71924100 @default.
• W4292294906 hasConceptScore W4292294906C86803240 @default.
• W4292294906 hasLocation W42922949061 @default.
• W4292294906 hasLocation W42922949062 @default.
• W4292294906 hasLocation W42922949063 @default.
• W4292294906 hasOpenAccess W4292294906 @default.
• W4292294906 hasPrimaryLocation W42922949061 @default.
• W4292294906 hasRelatedWork W1975094265 @default.

• next